Annual Report-2011-2012.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report-2011-2012.Pdf 56th AIIMS ANNUAL REPORT 2011-2012 All India Institute of Medical Sciences New Delhi 110029 Edited jointly by : Dr Sandeep Agarwala, Department of Paediatric Surgery Dr Sanjay Arya, Department of Hospital Administration & Registrar Dr Rohit Bhatia, Department of Neurology Dr Shakti Kumar Gupta, Dr R.P. Centre for Ophthalmic Sciences Dr Rakesh Lodha, Department of Paediatrics Dr Kalpana Luthra, Department of Biochemistry Dr Govind Makharia, Department of Gastroenterology Dr S. Ramakrishnan, Department of Cardiology Dr Peush Sahni, Department of Gastrointestinal Surgery Dr Pratap Sharan, Department of Psychiatry Dr Rakesh Yadav, Department of Cardiology & Sub-Dean (Acad.) March 2013 Printed at : Malhotra Enterprises : 9211402090, 9810492991 E-mail : [email protected] All India Institute of Medical Sciences The All India Institute of Medical Sciences (AIIMS) was established in 1956 as an institution of national importance by an Act of Parliament to develop patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education to all medical colleges and other allied institutions in India; to bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity and to attain self-sufficiency in postgraduate medical education. The Institute has comprehensive facilities for teaching, research and patient-care. AIIMS conducts teaching programmes in medical and para-medical courses both at the undergraduate and postgraduate levels and awards its own degrees. Teaching and research is conducted in 52 disciplines. AIIMS is a leader in the field of medical research having more than 1500 research publications by its faculty and researchers in a year. AIIMS also runs a College of Nursing, training students for B. Sc. (Hons.) Nursing and B. Sc. Nursing (Post-Certificate) degrees. Thirty-eight departments and seven super-speciality centres manage practically all types of disease conditions with support from pre-clinical and para-clinical services. AIIMS also runs a 50-bedded hospital and the Comprehensive Rural Health Centre at Ballabgarh in Haryana and provides health cover to about 7.7 lakh people through the Centre for Community Medicine. AIIMS AT A GLANCE 2011-2012 Year of establishment 1956 Teaching Departments and Centres 52 Medical graduates 2596 Faculty members (Sanctioned 823) 498 Postgraduates 7943 Non-faculty staff (Sanctioned 10847) 8702 Nursing / paramedical graduates 2481 No. of Undergraduate students 673 Publications in journals/abstracts 1733 No. of Postgraduate students 1383 Chapters in Books / monographs 240 Hospital Services Hospital/Centre Outpatient Surgery Bed Bed Total Attendance Admission (Operations/ (Gen.) (Pvt.) Bed (including Procedures) Strength Casualty) Main Hosp. 1522821 77055 73851 982 165 1147 Dr.R.P. Centre 397538 33881 32879 281 21 302 Dr.BRA,IRCH 84071 28872 6085 167 15 182 C.T. Centre 145497 11537 4252 174 32 * 206 N.S. Centre 109504 6876 3129 174 31 205 NDDTC 73070 875 0 50 0 50 C.C.M. 218064 7527 1572 50 0 50 JPNAT Centre 78077 4904 5026 186 0 186 CDER 127896 143 10589 0 0 0 Total 2756538 171670 137383 2064 264 2328 *1 bed (pvt.) is used 6 months by CT Centre and 6 months by NS Centre Average Length of stay* : 5.5 days Average Bed Occupancy rate (%)* : 81.6% Net Death Rate (%)* : 2.2% Combined Crude Infection Rate (%)* : 8.3% *These figures are for AIIMS Main Hospital only. CONTENTS 1. Director’s Review .................................................................................................................................... 1 2. Institute Body, AIIMS .............................................................................................................................. 5 3. Academic Section .................................................................................................................................. 10 4. Examination Section ............................................................................................................................... 16 5. General Administration ........................................................................................................................... 21 6. Main Hospital ......................................................................................................................................... 24 7. College of Nursing ................................................................................................................................. 44 8. Research Section ................................................................................................................................... 51 9. Departments 9.1 Anaesthesiology ..................................................................................................................................... 53 9.2 Anatomy ................................................................................................................................................ 57 9.3 Biochemistry .......................................................................................................................................... 64 9.4 Biomedical Engineering ........................................................................................................................... 71 9.5 Biophysics .............................................................................................................................................. 74 9.6 Biostatistics ............................................................................................................................................ 77 9.7 Biotechnology ........................................................................................................................................ 82 9.8 Centre for Community Medicine ............................................................................................................. 86 9.9 Dermatology and Venereology ................................................................................................................ 94 9.10 Emergency Medicine .............................................................................................................................. 97 9.11 Endocrinology and Metabolism .............................................................................................................. 99 9.12 Forensic Medicine ................................................................................................................................ 103 9.13 Gastroenterology and Human Nutrition ................................................................................................. 106 9.14 Gastrointestinal Surgery and Liver Transplantation ................................................................................ 113 9.15 Haematology ........................................................................................................................................ 116 9.16 Hospital Administration ......................................................................................................................... 121 9.17 Laboratory Medicine ............................................................................................................................ 125 9.18 Medicine .............................................................................................................................................. 136 9.19 Microbiology ........................................................................................................................................ 142 9.20 Nephrology .......................................................................................................................................... 151 9.21 Nuclear Medicine ................................................................................................................................. 156 9.22 Nuclear Magnetic Resonance ............................................................................................................... 158 9.23 Obstetrics and Gynaecology ................................................................................................................. 161 9.24 Orthopaedics ....................................................................................................................................... 172 9.25 Otorhinolaryngology (ENT) .................................................................................................................. 176 9.26 Paediatrics ........................................................................................................................................... 180 9.27 Paediatric Surgery ................................................................................................................................ 200 9.28 Pathology ............................................................................................................................................. 205 9.29 Pharmacology ...................................................................................................................................... 211 9.30 Physical Medicine and Rehabilitation .................................................................................................... 216 9.31 Physiology ............................................................................................................................................ 219 9.32 Psychiatry
Recommended publications
  • Equilibrium Radionuclide Angiography/ Multigated Acquisition
    EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY/ MULTIGATED ACQUISITION Equilibrium Radionuclide Angiography/ Multigated Acquisition S van Eeckhoudt, Bravis ziekenhuis, Roosendaal VJR Schelfhout, Rijnstate, Arnhem 1. Introduction Equilibrium radionuclide angiography (ERNA), also known as radionuclide ventriculography (ERNV), gated synchronized angiography (GSA), blood pool scintigraphy or multi gated acquisition (MUGA), is a well-validated technique to accurately determine cardiac function. In oncology its high reproducibility and low inter observer variability allow for surveillance of cardiac function in patients receiving potentially cardiotoxic anti-cancer treatment. In cardiology it is mostly used for diagnosis and prognosis of patients with heart failure and other heart diseases. 2. Methodology This guideline is based on available scientifi c literature on the subject, the previous guideline (Aanbevelingen Nucleaire Geneeskunde 2007), international guidelines from EANM and/or SNMMI if available and applicable to the Dutch situation. 3. Indications Several Class I (conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective) indications exist: • Evaluation of left ventricular function in cardiac disease: - Coronary artery disease - Valvular heart disease - Congenital heart disease - Congestive heart failure • Evaluation of left ventricular function in non-cardiac disease: - Monitoring potential cardiotoxic side effects of (chemo)therapy - Pre-operative risk stratifi cation in high risk surgery • Evaluation of right ventricular function: - Congenital heart disease - Mitral valve insuffi ciency - Heart-lung transplantation 4. Contraindications None 5. Medical information necessary for planning • Clear description of the indication (left and/or right ventricle) • Previous history of cardiac disease • Previous or current use of cardiotoxic medication PART I - 211 Deel I_C.indd 211 27-12-16 14:15 EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY/ MULTIGATED ACQUISITION 6.
    [Show full text]
  • Dde18june21.Pdf
    StudentId ROLLNO PROLLNO REGNO StudentName PAGE MName SUB1 SUB2 SUB3 SUB4 SUB5 SUB6 SUB7 174330 101010001 - 1025DDEJM20 BABLU SHARMA SHAM LAL SHARMA GEETA DEVI AA-101 ED-101 PY-101 GG-101 174331 101010002 - 1026DDEJM20 NITIN SHARMA ASHOK KUMAR ASHA DEVI AA-101 HT-101 SO-101 PS-101 174332 101010003 - 1027DDEJM20 AVNEET SINGH HARCHARAN SINGH RAVINDER KOUR AA-101 ED-101 PS-101 PU-101 174333 101010004 - 1028DDEJM20 TARUN SHARMA BHUSHAN LAL MAMTA DEVI AA-101 ED-101 SO-101 PS-101 174334 101010005 - 1029DDEJM20 KAMAL KUMAR VIJAY KUMAR JYOTI DEVI AA-101 ED-101 SO-101 PS-101 174464 101010006 - 1159DDEJM20 SHAID AHMED MOHD HAFIEEZ MANIZA BEGUM AA-101 ED-101 SO-101 GG-101 174466 101010007 - 1161DDEJM20 AJEET SINGH NARESH SINGH TRIPTA DEVI AA-101 ED-101 SO-101 PL-101 174468 101010008 - 1163DDEJM20 KAMALJEET KUMAR KALA RAM DARSHNA AA-101 ED-101 HT-101 HI-101 174469 101010009 - 1164DDEJM20 NAUSHAD AHMED AZAD MOHD RAZAQ AZMAT BI AA-101 HS-108 SO-101 PS-101 174470 101010010 - 1165DDEJM20 RAHUL KUMAR DARSHAN KUMAR ANITA DEVI AA-101 ED-101 PS-101 PL-101 174535 101010011 - 1230DDEJM20 KARTIK BHAN MAHRAJ KRISHAN BHAN PINKY BHAN AA-101 HT-101 SO-101 PS-101 174461 101010012 - 1156DDEJM20 PANKAJ SINGH CHARAK PARVEEN SINGH CHARAK JYOTI RANI AA-101 ED-101 SO-101 PS-101 174399 101010013 - 1094DDEJM20 SIDDHARATH SINGH BALI BAL KRISHAN BALI GIYAN DEVI AA-101 ED-101 HT-101 PS-101 174416 101010014 - 1111DDEJM20 ABHINASH SHARMA RAM LAL KAMLESH SHARMA AA-101 ED-101 PY-101 MA-101 174398 101010015 - 1093DDEJM20 BHUPINDER SINGH JASBIR SINGH TRIPTA DEVI AA-101 MA-101 PS-101
    [Show full text]
  • A Common Occurrence After Coronary Bypass Surgery
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector lACC Vol. 15, No.6 1261 May 1990:1261-9 Acute Myocardial Dysfunction and Recovery: A Common Occurrence After Coronary Bypass Surgery WARREN M. BREISBLATT, MD, FACC, KEITH L. STEIN, MD, CYNTHIA J. WOLFE, RN, WILLIAM P. FOLLANSBEE, MD, FACC, JOHN CAPOZZI, CNMT, JOHN M. ARMITAGE, MD, ROBERT L. HARDESTY, MD, FACC Pittsburgh, Pennsylvania To evaluate whether acute myocardial dysfunction was min after coronary bypass and showed complete recovery common in the early postoperative period, serial hemody• within 48 h. Left ventricular end-systolic and end-diastolic namic measurements and radionuclide evaluation of ven• volume index increased significantly postoperatively, but tricular function were performed before and after opera• recovery in left ventricular ejection fraction was mostly due tion in 24 patients undergoing elective coronary bypass to decreases in end-systolic volume index (50 ± 22 ml at surgery. All patients had uncomplicated surgery, and no trough and 32 ± 16 ml at recovery). Depressed myocardial patient sustained an intraoperative infarction. In 96% of function was independent of bypass time, number of grafts patients, significant depression in right and left ventricular placed, preoperative medications or core temperatures ejection fraction was seen postoperatively, reaching a nadir postoperatively. Postoperative therapy with pressors or at 262 ± 116 min after coronary bypass. Left ventricular inotropic agents delayed but did
    [Show full text]
  • Sr No Marks Student Name Father Name School Name 1
    SR NO MARKS STUDENT NAME FATHER NAME SCHOOL NAME 1 681 VAISHNAVI THAKUR SHIV CHARAN DASS ARYAN PUBLIC SR SEC SCHOOL, JHIRIWALA 2 679 VAIBHAV VASHISTH HEM RAJ S.VIDYA MANDIR HIGH SCHOOL, GHUMARWIN 3 679 ANCHAL GUPTA MAHESH KUMAR GUPTA S V N PUBLIC SCHOOL, NAHAN 4 679 NIKHIL SHARMA OM PRAKASH SHARMA S V M HIGH SCHOOL, DALASH 5 679 EESHA PANKAJ KUMAR ARYAN PUBLIC SCHOOL, BILASPUR 6 675 NAMRATA SHARMA BINDER SHARMA ARYAN PUBLIC SR SEC SCHOOL, JHIRIWALA 7 674 POOJA SHARMA RAMESH KUMAR S.VIDYA MANDIR HIGH SCHOOL, GHUMARWIN 8 674 ANKITA HARDEV SINGH SWAMI VIVEKANAND PUBLIC SR SEC SCHOOL, GAGRET 9 673 SANCHIT GOEL SANJAY GOEL BINWA PUBLIC SR SEC SCHOOL, BAIJNATH 10 673 MANYA BHARDWAJ CHANDAN BHARDWAJ HIM ACADEMY PUBLIC SCHOOL, VIKAS NAGAR 11 673 NANCY JASWAL JASBIR KUMAR NEW ERA SR SEC SCHOOL, PAROL 12 672 SHAMLI SHARMA AJAY KUMAR SHARMA BHARTIYA PUB SR SEC SCHOOL, JOGINDER NAGAR 13 672 PRIYANKA BHARDWAJ TEG SINGH SNOWER VALLEY PUBLIC SCHOOL, BAJAURA 14 672 SHIKHA JASWAL AJAY KUMAR JASWAL ST. D R PUBLIC SR SEC SCHOOL, GAGRET 15 672 VARUN SHARMA SATISH KUMAR HIM ACADEMY PUBLIC SCHOOL, VIKAS NAGAR 16 672 TAMNNA SHARMA DESH RAJ SHISHU MODEL SR.SEC.SCHOOL, TALAI 17 671 SHIVALIKA KUMARI SHAMSHER SINGH KID BUDS PUBLIC SR SEC SCHOOL, PANGA (BIJHARI) 18 671 PURNIMA SHARMA NAVENDER KUMARSANKHYAN HIM SARVODAYA SR SEC SCHOOL, GHUMARWIN 19 671 DEEPANSHU THAKUR JAI KRISHAN THAKUR NAV JYOTI PUBLIC SCHOOL, SARWARI 20 671 DEEKSHA SHARMA RAJESH SHARMA HIM SARVODAYA SR SEC SCHOOL, GHUMARWIN 21 670 MANVEER KULBIR SINGH BINWA PUBLIC SR SEC SCHOOL, BAIJNATH 22 670
    [Show full text]
  • Padma Vibhushan S. No. Name of the Awardee Discipline State/Domicile
    Padma Vibhushan S. State/Domicile Name of the Awardee Discipline No. 1. Shri L. K. Advani Public Affairs Gujarat 2. Shri Amitabh Bachchan Art Maharashtra 3. Shri Prakash Singh Badal Public Affairs Punjab 4. Dr. D. Veerendra Heggade Social Work Karnataka Shri Mohammad Yusuf 5. Art Maharashtra Khan alias Dilip Kumar Shri Jagadguru 6. Ramanandacharya Swami Others Uttar Pradesh Rambhadracharya Prof. Malur Ramaswamy Science and 7. Tamil Nadu Srinivasan Engineering Shri Kottayan K. 8. Venugopal Public Affairs Delhi Shri Karim Al Hussaini Trade and 9. France/UK Aga Khan ( Foreigner) Industry Padma Bhushan Shri Jahnu Barua 1. Art Assam Dr. Vijay Bhatkar Science and 2. Maharashtra Engineering 3. Literature and Shri Swapan Dasgupta Delhi Education 4. Swami Satyamitranand Giri Others Uttar Pradesh 5. Shri N. Gopalaswami Civil Service Tamil Nadu 6. Dr. Subhash C. Kashyap Public Affairs Delhi Dr. (Pandit) Gokulotsavji Madhya 7. Art Maharaj Pradesh 8. Dr. Ambrish Mithal Medicine Delhi 9. Smt. Sudha Ragunathan Art Tamil Nadu 10. Shri Harish Salve Public Affairs Delhi 11. Dr. Ashok Seth Medicine Delhi 12. Literature and Shri Rajat Sharma Delhi Education 13. Shri Satpal Sports Delhi 14. Shri Shivakumara Swami Others Karnataka Science and 15. Dr. Kharag Singh Valdiya Karnataka Engineering Prof. Manjul Bhargava Science and 16. USA (NRI/PIO) Engineering 17. Shri David Frawley Others USA (Vamadeva) (Foreigner) 18. Shri Bill Gates Social Work USA (Foreigner) 19. Ms. Melinda Gates Social Work USA (Foreigner) 20. Shri Saichiro Misumi Others Japan (Foreigner) Padma Shri 1. Dr. Manjula Anagani Medicine Telangana Science and 2. Shri S. Arunan Karnataka Engineering 3. Ms. Kanyakumari Avasarala Art Tamil Nadu Literature and Jammu and 4.
    [Show full text]
  • Result Gazette
    UNIVERSITY OF JAMMU RESULT GAZETTE B.Ed. Semester-I Examination 2019-21 Held in February 2020 (Errors & Omissions Excepted) PUBLISHED BY: Controller of Examinations University of Jammu Baba Sahib Ambedkar Road Jammu-180006 Date: 21st August 2020 With Best Compliments From Controller of Examinations Re-evaluation Dates With prescribed Fee upto 31-08-2020 With late Fee upto 03-09-2020 The applicants shall submit their Online application forms for re-evaluation by following the below mentioned steps w. e. f. 22-08-2020 : - I. Logon to www.coeju.com II. Click on Re-evaluation of 1st Semester icon, fill up their Roll No. and a pre-filled candidate specific re-evaluation form will pop-up. III. Select the subject(s) in which the candidate is desirous of availing the re- evaluation. IV. The candidates shall submit the prescribed fee through online mode only. V. The candidates are not required to submit the hard copy of the re-evaluation form. VI. The candidates are required to get the print of the receipt for online payment and preserve it for reference. ATTENTION ALL CANDIDATES Candidates wishing to apply for Re-evaluation are advised to conscientiously peruse the below mentioned Statutes before doing so:- 1. The fee for Re-evaluation shall be Rs. 810/- (or as notified from time to time) per answer script for a count of 10 days from the date of declaration of main result (excluding the day of declaration of main result). The form shall also be accepted with a late fee of Rs. 450/- (or as notified from time to time) per answer script for another count of 3 days, Late fee of Rs.
    [Show full text]
  • Annexure – 4A) Sr
    Taxpayers assigned to the Central Tax Administration, GST & CE Commissionerate Jalandhar (List of 4729 Taxpayers enclosed as Annexure – 4A) Sr. No. Taxpayer Name GSTIN 1 INSTANT PHARMACEUTICALS 03AACFI8220J1ZN 2 PAWAN GROVER 03ADWPG1022H1ZX 3 HARPREET SINGH AHLUWALIA 03AHAPA7483N1ZB 4 RAJAN VERMA 03ABXPV7908G1Z0 5 JASWINDER KAUR 03EDUPK6711F1ZH 6 JARMAN SINGH 03DENPS7195G1ZX 7 PARUL ARORA 03AGUPA6082C1ZN 8 SHANKER THERMOCOL PRODUCTS 03ACUFS6457P1Z4 9 JASPAL SINGH 03BCAPS9046M1Z9 10 GAGANDEEP SINGH 03ECGPS7699B1Z8 11 RAMJI DAS KASTURI LAL 03AAAFR9855J1ZX 12 YOWAN NANDA 03AAGPN5564L1ZG 13 KIRPAL SINGH 03AKHPS9259E1ZW 14 SANJEEV KUMAR 03AAYPK0151G1ZV 15 KISHORE CHAND 03AEAPC3203R1ZX 16 THE SERVICE CLUB 03AABAT1061C1Z9 17 RAGHBIR SINGH 03AJXPS5250L1ZK 18 JASPAL KAUR 03AAXPK7168C1ZH 19 SUMIT KHANNA 03ATCPK2231Q1ZS 20 UMESH KUMAR BHAMBRI 03ADIPB2866N1ZH 21 VINOD KUMAR 03ABEPK2066R1ZG 22 MADAN LAL CHHABRA 03AEUPC8229B1ZQ 23 RAJIV MEHRA 03ABQPM1297C1ZQ 24 JASPREET SINGH SABHARWAL 03ACAPS0168F1Z0 25 METAL MOULD (INDIA) 03AABFM3670P1Z4 26 BIRINDER KUMAR SHARMA 03AFDPS8955G1Z6 27 RAJIV KAPOOR 03AFLPK8790H1Z3 28 NARAIN DASS NAND KISHORE 03AAAFN7184L1Z3 29 RAVINDER SINGH 03BOLPS9227K1ZE 30 AMRITSAR PHARMA AGENCIES 03AABFA6171D1Z3 31 BANSAL HARDWARE STORE 03AADFB4415D1Z9 32 VINOD KUMAR 03ABSPK4519P1Z4 33 DEEPAK AHUJA 03AALPA7738G1ZV 34 SUDESH SHARMA 03ABTPS3293B1ZJ 35 SUKHWINDER KAUR 03DNJPK6940J1ZS 36 HARPREET SINGH 03AONPS0059Q1ZD 37 GURDEV SINGH 03AMDPS1675E1Z8 38 AMNINDERJIT SINGH 03BGPPS8566P1Z9 39 PREM KUMAR 03ABBPK5784D1ZX 40 GOVIND MEHRA HUF
    [Show full text]
  • Evicore Ped Cardiac Imaging Guidelines V19.0
    CLINICAL GUIDELINES Pediatric Cardiac Imaging Policy Version 19.0 Effective May 22nd, 2017 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2016 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2017 eviCore healthcare. All rights reserved. PEDIATRIC CARDIAC IMAGING GUIDELINES PEDIATRIC CARDIAC IMAGING GUIDELINES PEDCD-1~GENERAL GUIDELINES 3 PEDCD-2~CONGENITAL HEART DISEASE 8 PEDCD-3~HEART MURMUR 10 PEDCD-4~CHEST PAIN 11 PEDCD-5~SYNCOPE 13 PEDCD-6~KAWASAKI DISEASE 15 PEDCD-7~PEDIATRIC PULMONARY HYPERTENSION 16 PEDCD-8~ECHOCARDIOGRAPHY—OTHER INDICATIONS 17 PEDCD-9~CARDIAC MRI—OTHER INDICATIONS 21 PEDCD-10~CT HEART AND CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CCTA)—OTHER INDICATIONS 24 V19.0- Pediatric Cardiac Imaging Page 2 of 26 PEDIATRIC CARDIAC
    [Show full text]
  • Mobile Multiwire Gamma Camera for First-Pass Radionuclide Angiography
    IMAGING Mobile Multiwire Gamma Camera for First-Pass Radionuclide Angiography Gerald W. Guidry, Jeffrey L. Lacy, Shigeyuki Nishimura, John J. Mahmarian, Terri M. Boyce, and Mario S. Verani Baylor College ofMedicine and The Methodist Hospital, Houston, Texas The purpose of this paper is to describe this new, portable In this paper, we describe a compact mobile multiwire gamma MWGC, the improved technique to acquire and process camera (MWGC) dedicated to first-pass radionuclide an­ FPRNA, and the new portable 178W j178Ta generator. The giography (FPRNA). Studies with this camera are performed portability of the system allows studies to be performed at the utilizing the short-lived (T•;, = 9.3 min) isotope tantalum-178 patient's bedside anywhere in the hospital. In this report, we 178 ( Ta), eluted (up to 100 mCi doses) at the patient's bedside illustrate the use of the system in the catheterization labora­ from a portable tungsten-tantalum generator. Processing is tory. completed on-site within -8 min, including calculation of right and left ventricular (LV) ejection fraction (EF), ejection rate, peak filling rate (PFR), and time to peak ejection and MATERIALS AND METHODS filling. Regional ventricular volume curves allow assessment of segmental ejection and filling indices. In a recent study, Multlwlre Gamma Camera high count-rate FPRNA was performed before and during The MWGC has a lightweight detector (23 kg), an onboard coronary angioplasty in the cardiac catheterization labora­ computer for imaging acquisition and processing, and a high tory. During coronary angioplasty, a significant transient resolution display for image processing and interpretation. depression in LV function was seen: the LV EF fell from 52% The basic design of the wire chamber detector has been ± 12% to 40% ± U% (p 0.0001) and the PFRfrom 2.4 ± = previously reported (1 ).
    [Show full text]
  • High Court of Delhi Advance Cause List
    HIGH COURT OF DELHI ADVANCE CAUSE LIST LIST OF BUSINESS FOR TH TUESDAY, THE 25 SEPTEMBER, 2018 INDEX PAGES 1. APPELLATE JURISDICTION 01 TO 55 2. COMPANY JURISDICTION 56 TO 61 3. ORIGINAL JURISDICTION 62 TO 77 4. REGISTRAR GENERAL/ 78 TO 89 REGISTRAR(ORGL.)/ REGISTRAR (ADMN.)/ JOINT REGISTRARS(ORGL). 25.09.2018 1 (APPELLATE JURISDICTION) 25.09.2018 [Note : Unless otherwise specified, before all appellate side courts, fresh matters shown in the supplementary lists will be taken up first.] COURT NO. 1 (DIVISION BENCH-I) HON'BLE THE CHIEF JUSTICE HON'BLE MR. JUSTICE V. KAMESWAR RAO FRESH MATTERS & APPLICATIONS ______________________________ 1. W.P.(C) 9618/2018 T. VENKATRAM REDDY AND ANR. PRASHANT KUMAR CM APPL. 37434/2018 Vs. M/S INDIABULLS HOUSING CM APPL. 37435/2018 FINANCE LTD AND ORS. CM APPL. 37436/2018 CM APPL. 38052/2018 FOR ADMISSION _______________ 2. LPA 479/2018 IDBI BANK LTD SIDHARTHA BARUA,ARVIND KUMAR CM APPL. 34392/2018 Vs. RAVI PRAKASH GOYAL & ORS GUPTA,ANIL SONI 3. CM APPL. 17859/2018 S.B. TRIPATHI PETITIONER IN PERSON,S B In W.P.(C) 3519/2016 Vs. GOVT. OF NCT OF DELHI & TRIPATHI,ANUJ AGGARWAL,SUMEET ANR PUSHKARNA (Disposed-off Case) 4. W.P.(C) 4870/2017 ADANI POWER MAHARASHTRA LTD SUJIT GHOSE ADVAITA WITH W.P.(C) 9578/2017 Vs. UNION OF INDIA AND ORS LEGAL,SANJEEV NARULA 5. W.P.(C) 9578/2017 ADANI POWER MAHARASHTRA LTD. ADVAITA LEGAL,SANJEEV NARULA CM APPL. 38992/2017 Vs. UNION OF INDIA & ORS. AFTER NOTICE MISC. MATTERS ____________________________ 6. FAO(OS) 105/2018 VHB LIFE SCIENCES INC RAVIKESH KUMAR SINHA,PRAVIN CM APPL.
    [Show full text]
  • EANM Procedural Guidelines for Radionuclide Myocardial Perfusion Imaging with SPECT and SPECT/CT
    EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT Chair of writing committee (responsible for the coordination of the overall process): Hein J. Verberne and Birger Hesse Authors: Hein J. Verberne, Wanda Acampa, Constantinos Anagnostopoulos, Jim Ballinger, Frank Bengel, Pieter De Bondt, Ronny R. Buechel, Alberto Cuocolo, Berthe L.F. van Eck-Smit, Albert Flotats, Marcus Hacker, Cecilia Hindorf, Philip A. Kaufmann, Oliver Lindner, Michael Ljungberg, Markus Lonsdale, Alain Manrique, David Minarik, Arthur J.H.A. Scholte, Riemer H.J.A. Slart, Elin Trägårdh, Tim C. de Wit, Birger Hesse Correspondence to: H.J. Verberne, MD PhD Department of Nuclear Medicine, F2-238 Academic Medical Center University of Amsterdam Meibergdreef 9 1105 AZ Amsterdam The Netherlands Tel: *31-20-5669111, pager 58 436 Fax: *31-20-5669092 E-mail: [email protected] 1 Author affiliations: H.J. Verberne Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Tel: +31 20 566 9111, pager 58 436 Fax: +31 20 566 9092 E-mail: [email protected] W. Acampa Institute of Biostructures and Bioimaging, National Council of Research, Naples, Italy Tel: +39 0812203409 Fax: +39 0815457081 E-mail: [email protected] C. Anagnostopoulos Center for Experimental surgery, Clinical and Translational Research, Biomedical research foundation, Academy of Athens, Greece Tel: +30 210 65 97 126 or +30 210 65 97 067 Fax: +30 210 65 97 502 E-mail: [email protected] J. Ballinger Department of Nuclear Medicine, Guy's Hospital - Guy's & St Thomas' Trust Foundation, London, United Kingdom Tel: +44 207 188 5521 Fax: +44 207 188 4094 E-mail: [email protected] F.
    [Show full text]
  • 2009 Appropriate Use Critera for Cardiac Radionuclide Imaging
    Appropriate Use Criteria for Cardiac Radionuclide Imaging Ratings Moderator 1 2 3 4 5 6 7 8 9 101112131415 Indication Median MADM R Agree Table 1. Detection of CAD: Symptomatic Evaluation of Ischemic Equivalent (Non-Acute) 1 • Low pre-test probability of CAD 4 2 1 5 1 3 4 2 1 5 3 2 4 3 3 3 1.1 I • ECG interpretable AND able to exercise 2 • Low pre-test probability of CAD 9 7 3 9 5 7 6 7 7 8 8 8 7 7 5 7 1.1 A + • ECG uninterpretable OR unable to exercise 3 • Intermediate pre-test probability of CAD 9 728173788877 7 7 7 1.4 A + • ECG interpretable AND able to exercise 4 • Intermediate pre-test probability of CAD 9 9 8 9 7 8 9 9 99 9 9 9 9 9 9 0.3 A + • ECG uninterpretable OR unable to exercise 5 • High pre-test probability of CAD 9 9 59 5 8 6 8 7 5 8 7 6 8 9 8 1.3 A • Regardless of ECG interpretability and ability to exercise Acute Chest Pain 6 • Possible ACS 9 9 8 8 7 8 7 8 3 8 7 8 7 8 6 8 0.9 A + • ECG—no ischemic changes or with LBBB or electronically paced ventricular rhythm • Low-Risk TIMI Score • Peak Troponin: borderline, equivocal, minimally elevated 7 • Possible ACS 9 8 1 9 2 8 5 8 1 7 7 7 5 8 9 7 2.1 A • ECG—no ischemic changes or with LBBB or electronically paced ventricular rhythm • High-Risk TIMI Score • Peak Troponin: borderline, equivocal, minimally elevated 8 • Possible ACS 9 8 9 9 3 7 3 8 8 8 7 8 8 7 4 8 1.3 A + • ECG—no ischemic changes or with LBBB or electronically paced ventricular rhythm • Low-Risk TIMI Score • Negative troponin levels 9 • Possible ACS 9 9 8 9 7 5 7 9 1 8 6 7 8 8 8 8 1.3 A + • ECG—no ischemic changes or with LBBB or electronically paced ventricular rhythm • High-Risk TIMI Score • Negative troponin levels 10 • Definite ACS 111312111111122 1 0.3 I + Acute Chest Pain (Rest Imaging Only) 11 • Possible ACS 9 9 7 7 7 2 68 9 2 8 6 8 8 6 7 1.5 A • ECG—no ischemic changes or with LBBB or electronically paced ventricular rhythm • Initial troponin negative • Recent or on-going chest pain Table 2.
    [Show full text]